Mycophenolate Mofetil Therapy for Pediatric Bullous Pemphigoid
Document Type
Article
Publication Date
1-1-2015
Description
Bullous pemphigoid (BP) is a common autoimmune blistering disease in the adult population, but extremely rare in the pediatric population. Childhood BP usually has a favorable prognosis and responds well to topical and oral steroids. However, for patients that do not respond to corticosteroids, therapeutic alternatives are scarce. We report a case of a toddler with recalcitrant BP who was successfully treated with mycophenolate mofetil (MMF).
Citation Information
Seminario-Vidal, Lucia; Sami, Naveed; Miller, Jonathan; and Theos, Amy. 2015. Mycophenolate Mofetil Therapy for Pediatric Bullous Pemphigoid. Dermatology Online Journal. Vol.21(8). https://pubmed.ncbi.nlm.nih.gov/26437160/ PMID: 26437160 ISSN: 1087-2108